{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:14:02Z","timestamp":1777493642660,"version":"3.51.4"},"reference-count":73,"publisher":"Elsevier BV","issue":"17-18","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.lfs.2011.02.020","type":"journal-article","created":{"date-parts":[[2011,2,27]],"date-time":"2011-02-27T14:33:27Z","timestamp":1298817207000},"page":"784-791","source":"Crossref","is-referenced-by-count":26,"title":["Suppressing inflammatory cascade by cyclo-oxygenase inhibitors attenuates quinolinic acid induced Huntington's disease-like alterations in rats"],"prefix":"10.1016","volume":"88","author":[{"given":"Harikesh","family":"Kalonia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2011.02.020_bb0005","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1515\/bc.2010.070","article-title":"The mitochondria permeability transition pore complex in the brain with interacting proteins \u2014 promising targets for protection in neurodegenerative diseases","volume":"391","author":"Azarashvili","year":"2010","journal-title":"Biol Chem"},{"key":"10.1016\/j.lfs.2011.02.020_bb0010","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1523\/JNEUROSCI.08-10-03901.1988","article-title":"Systemic approaches to modifying quinolinic acid striatal lesions in rats","volume":"8","author":"Beal","year":"1988","journal-title":"J Neurosci"},{"key":"10.1016\/j.lfs.2011.02.020_bb0015","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1523\/JNEUROSCI.11-06-01649.1991","article-title":"Chronic quinolinic acid lesions in rats closely resemble Huntington's disease","volume":"11","author":"Beal","year":"1991","journal-title":"J Neurosci"},{"key":"10.1016\/j.lfs.2011.02.020_bb0020","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1590\/S0100-879X2006005000109","article-title":"A mechanistic view of mitochondrial death decision pores","volume":"40","author":"Beliz\u00e1rio","year":"2007","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.lfs.2011.02.020_bb0025","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1046\/j.1471-4159.1999.0731127.x","article-title":"Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease","volume":"73","author":"Berman","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.lfs.2011.02.020_bb0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0006-8993(95)00150-O","article-title":"Asymmetrical motor behavior in rats with unilateral striatal excitotoxic lesions as revealed by the elevated body swing test","volume":"676","author":"Borlongan","year":"1995","journal-title":"Brain Res"},{"key":"10.1016\/j.lfs.2011.02.020_bb0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0022-510X(90)90114-3","article-title":"The quinolinic acid hypothesis in Huntington's chorea","volume":"95","author":"Bruyn","year":"1990","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.lfs.2011.02.020_bb0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/exnr.2002.8044","article-title":"Mitochondrial complex inhibitors preferentially damage substantia nigra dopamine neurons in rat brain slices","volume":"179","author":"Bywood","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.lfs.2011.02.020_bb0045","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0028-3908(99)00128-8","article-title":"Melatonin reduces oxidative neurotoxicity due to quinolinic acid: in vitro and in vivo findings","volume":"39","author":"Cabrera","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2011.02.020_bb0050","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/neu.480230915","article-title":"Excitotoxic cell death","volume":"23","author":"Choi","year":"1992","journal-title":"J Neurobiol"},{"key":"10.1016\/j.lfs.2011.02.020_bb0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-4615-0135-0_4","article-title":"Quinolinic acid up-regulates chemokine production and chemokine receptor expression in astrocytes","volume":"527","author":"Croitoru-Lamoury","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.lfs.2011.02.020_bb0060","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.pnpbp.2006.06.003","article-title":"Effect of cyclooxygenase inhibitors on pentylenetetrazol (PTZ)-induced convulsions: possible mechanism of action","volume":"30","author":"Dhir","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.lfs.2011.02.020_bb0065","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1006\/exnr.1993.1006","article-title":"Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterisation","volume":"119","author":"Ferrante","year":"1993","journal-title":"Exp Neurol"},{"key":"10.1016\/j.lfs.2011.02.020_bb0070","doi-asserted-by":"crossref","unstructured":"Ferreira, I.L., Nascimento, M.V., Ribeiro, M., Almeida, S., Cardoso, S.M., Grazina, M., et al. Mitochondrial-dependent apoptosis in Huntington's disease human cybrids. Exp Neurol 222:243\u201355.","DOI":"10.1016\/j.expneurol.2010.01.002"},{"key":"10.1016\/j.lfs.2011.02.020_bb0075","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0304-3940(84)90050-8","article-title":"Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid","volume":"48","author":"Foster","year":"1984","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.lfs.2011.02.020_bb0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2005.05.031","article-title":"The dual role of prostaglandin E(2) in excitotoxicity and preconditioning-induced neuroprotection","volume":"517","author":"Gendron","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.lfs.2011.02.020_bb0085","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0361-9230(90)90085-E","article-title":"MK801 prevents quinolinic acid-induced behavioral deficits and neurotoxicity in the striatum","volume":"24","author":"Giordano","year":"1990","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.lfs.2011.02.020_bb0090","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0021-9258(18)57021-6","article-title":"Determination of serum proteins by means of the biuret reaction","volume":"177","author":"Gornall","year":"1949","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lfs.2011.02.020_bb0095","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.lfs.2011.02.020_bb0100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pbb.2009.07.018","article-title":"Protective effect of cyclooxygenase (COX)-inhibitors against drug-induced catatonia and MPTP-induced striatal lesions in rats","volume":"94","author":"Gupta","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.lfs.2011.02.020_bb0105","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1471-4159.2006.03907.x","article-title":"Oxidative stress and neurodegeneration: where are we now?","volume":"97","author":"Halliwell","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.lfs.2011.02.020_bb0110","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/brain\/115.5.1249","article-title":"Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease","volume":"115","author":"Heyes","year":"1992","journal-title":"Brain"},{"key":"10.1016\/j.lfs.2011.02.020_bb0115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-2094-2-27","article-title":"Maximal COX-2 and ppRb expression in neurons occurs during early Braak stages prior to the maximal activation of astrocytes and microglia in Alzheimer's disease","volume":"2","author":"Hoozemans","year":"2005","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.lfs.2011.02.020_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/089771502753460196","article-title":"Cyclooxygenase inhibition as a strategy to ameliorate brain injury","volume":"19","author":"Hurley","year":"2002","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.lfs.2011.02.020_bb0125","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF03179878","article-title":"Mitochondrial control of neuron death and its role in neurodegenerative disorders","volume":"59","author":"Jord\u00e1n","year":"2003","journal-title":"J Physiol Biochem"},{"key":"10.1016\/j.lfs.2011.02.020_bb0130","first-page":"880","article-title":"Neuroprotective effect of MK-801 against intra-striatal quinolinic acid induced behavioral, oxidative stress and cellular alterations in rats","volume":"47","author":"Kalonia","year":"2009","journal-title":"Indian J Exp Biol"},{"key":"10.1016\/j.lfs.2011.02.020_bb0135","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuro.2009.12.008","article-title":"Protective effect of rofecoxib and nimesulide against intra-striatal quinolinic acid-induced behavioral, oxidative stress and mitochondrial dysfunctions in rats","volume":"31","author":"Kalonia","year":"2010","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.lfs.2011.02.020_bb0140","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0076-6879(67)10061-X","article-title":"Preparation of succinate dehydrogenase and reconstitution of succinate oxidase","volume":"10","author":"King","year":"1967","journal-title":"Meth Enzymol"},{"key":"10.1016\/j.lfs.2011.02.020_bb0145","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0076-6879(67)10055-4","article-title":"Preparations and properties of soluble NADH dehydrogenases from cardiac muscle","volume":"10","author":"King","year":"1967","journal-title":"Meth Enzymol"},{"key":"10.1016\/j.lfs.2011.02.020_bb0150","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1124\/jpet.107.119545","article-title":"Role of Ca2+\u2212 independent phospholipase A2gamma in Ca2+\u2212induced mitochondrial permeability transition","volume":"321","author":"Kinsey","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.lfs.2011.02.020_bb0155","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0003-9861(78)90479-4","article-title":"Generation of superoxide radical during auto-oxidation of hydroxylamine and an assay of superoxide dismutase","volume":"186","author":"Kono","year":"1978","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.lfs.2011.02.020_bb0160","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/01.RES.59.6.612","article-title":"PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH","volume":"59","author":"Kukreja","year":"1986","journal-title":"Circ Res"},{"key":"10.1016\/j.lfs.2011.02.020_bb0165","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1472-8206.2007.00485.x","article-title":"Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms","volume":"21","author":"Kumar","year":"2007","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.lfs.2011.02.020_bb0170","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1161\/01.STR.32.5.1220","article-title":"Neuroprotection by the selective cyclooxygenase-2 inhibitor SC-236 results in improvements in behavioral deficits induced by reversible spinal cord ischemia","volume":"32","author":"Lapchak","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.lfs.2011.02.020_bb0175","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.plefa.2010.02.006","article-title":"Polyunsaturated fatty acids, neuroinflammation and well being","volume":"82","author":"Lay\u00e9","year":"2010","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.lfs.2011.02.020_bb0180","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1515\/CCLM.1998.132","article-title":"Activated immune system in patients with Huntington's disease","volume":"36","author":"Leblhuber","year":"1998","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.lfs.2011.02.020_bb0185","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/exnr.2002.7864","article-title":"Phenformin suppresses calcium responses to glutamate and protects hippocampal neurons against excitotoxicity","volume":"175","author":"Lee","year":"2002","journal-title":"Exp Neurol"},{"key":"10.1016\/j.lfs.2011.02.020_bb0190","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1471-4159.1997.69020581.x","article-title":"Mechanisms of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolinium bromide (MTT) reduction","volume":"69","author":"Liu","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.lfs.2011.02.020_bb0195","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00018-007-6516-1","article-title":"Molecular targets of non-steroidal anti-inflammatory drugs in neurodegenerative diseases","volume":"64","author":"Lleo","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.lfs.2011.02.020_bb0200","series-title":"Methods of enzyme analysis","article-title":"Catalase","author":"Luck","year":"1971"},{"key":"10.1016\/j.lfs.2011.02.020_bb0205","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.4049\/jimmunol.177.9.6398","article-title":"Evidence against calcium as a mediator of mitochondrial dysfunction during apoptosis induced by arachidonic acid and other free fatty acids","volume":"177","author":"Maia","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.lfs.2011.02.020_bb0210","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1096\/fj.14.10.1464","article-title":"Putative role of neuronal 5-lipoxygenase in an aging brain","volume":"14","author":"Manev","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.lfs.2011.02.020_bb0215","doi-asserted-by":"crossref","first-page":"24794","DOI":"10.1074\/jbc.271.40.24794","article-title":"Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus. Inhibition by a platelet-activating factor antagonist","volume":"271","author":"Marcheselli","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lfs.2011.02.020_bb0220","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jnen\/63.9.901","article-title":"Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases","volume":"63","author":"Minghetti","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.lfs.2011.02.020_bb0225","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/1-4020-5688-5_5","article-title":"Role of COX-2 in inflammatory and degenerative brain diseases","volume":"42","author":"Minghetti","year":"2007","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.lfs.2011.02.020_bb0230","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/nen.0b013e3180517477","article-title":"Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegeneration","volume":"66","author":"Minghetti","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.lfs.2011.02.020_bb0235","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00109-009-0500-1","article-title":"Prostanoids and inflammation: a new concept arising from receptor knockout mice","volume":"87","author":"Narumiya","year":"2009","journal-title":"J Mol Med"},{"key":"10.1016\/j.lfs.2011.02.020_bb0240","first-page":"8","article-title":"Changes of mitochondria membrane potential and cytoplasmic cytochrome C in neuron apoptosis induced by benzo(a)pyrene","volume":"28","author":"Nie","year":"2010","journal-title":"Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi"},{"key":"10.1016\/j.lfs.2011.02.020_bb0245","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.lfs.2011.02.020_bb0250","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/jir.1997.17.589","article-title":"Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-\u03b1, and IFN-\u03b1","volume":"17","author":"Pemberton","year":"1997","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.lfs.2011.02.020_bb0255","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1046\/j.1471-4159.2002.00897.x","article-title":"In vivo activation of N-methyl-D-aspartate receptors in the rat hippocampus increases prostaglandin E(2) extracellular levels and triggers lipid peroxidation through cyclooxygenase-mediated mechanisms","volume":"81","author":"Pepicelli","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.lfs.2011.02.020_bb0260","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.neuint.2004.06.008","article-title":"S-allylcysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats","volume":"45","author":"P\u00e9rez-Severiano","year":"2004","journal-title":"Neurochem Int"},{"key":"10.1016\/j.lfs.2011.02.020_bb0265","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12017-008-8044-z","article-title":"Mitochondrial medicine for aging and neurodegenerative diseases","volume":"10","author":"Reddy","year":"2008","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.lfs.2011.02.020_bb0270","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molmed.2007.12.002","article-title":"Amyloid beta, mitochondrial dysfunction, and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease","volume":"14","author":"Reddy","year":"2008","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.lfs.2011.02.020_bb0275","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainresrev.2009.04.001","article-title":"Mitochondrial structural and functional dynamics in Huntington's disease","volume":"61","author":"Reddy","year":"2009","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.lfs.2011.02.020_bb0280","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/j.1471-4159.2006.04199.x","article-title":"Evidence that quinolinic acid severely impairs energy metabolism through activation of NMDA receptors in striatum from developing rats","volume":"99","author":"Ribeiro","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.lfs.2011.02.020_bb0285","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-4886(89)90170-2","article-title":"The quinolinic acid model of Huntington's disease: locomotor abnormalities","volume":"105","author":"Sanberg","year":"1989","journal-title":"Exp Neurol"},{"key":"10.1016\/j.lfs.2011.02.020_bb0290","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0304-3940(93)90796-N","article-title":"MK-801, an N-methyl-D-aspartate receptor antagonist, blocks quinolinic acid-induced lipid peroxidation in rat corpus striatum","volume":"159","author":"Santamar\u00eda","year":"1993","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.lfs.2011.02.020_bb0295","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbr.2006.10.004","article-title":"Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease","volume":"176","author":"Scattoni","year":"2007","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.lfs.2011.02.020_bb0300","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.6849138","article-title":"Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain","volume":"219","author":"Schwarcz","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.lfs.2011.02.020_bb0305","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0024-3205(84)90148-6","article-title":"Excitotoxic models for neurodegenerative disorders","volume":"35","author":"Schwarcz","year":"1984","journal-title":"Life Sci"},{"key":"10.1016\/j.lfs.2011.02.020_bb0310","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1749-6632.2009.04707.x","article-title":"Changes of mitochondria and relocation of the apoptosis-inducing factor during apoptosis","volume":"1171","author":"Scovassi","year":"2009","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.lfs.2011.02.020_bb0315","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0278-5846(98)00070-0","article-title":"Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease","volume":"22","author":"Shear","year":"1998","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.lfs.2011.02.020_bb0320","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1083\/jcb.32.2.415","article-title":"An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study","volume":"32","author":"Sottocasa","year":"1967","journal-title":"J Cell Biol"},{"key":"10.1016\/j.lfs.2011.02.020_bb0325","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0031-6997(25)00441-7","article-title":"Neuropharmacology of quinolinic and kynurenic acids","volume":"45","author":"Stone","year":"1993","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.lfs.2011.02.020_bb0330","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0014-2999(81)90587-2","article-title":"Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS","volume":"72","author":"Stone","year":"1981","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.lfs.2011.02.020_bb0335","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2174\/1568010054022051","article-title":"Prostaglandins and cyclooxygenases in glial cells during brain inflammation","volume":"4","author":"Tzeng","year":"2005","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.1016\/j.lfs.2011.02.020_bb0340","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.expneurol.2006.01.034","article-title":"Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease","volume":"199","author":"Vazey","year":"2006","journal-title":"Exp Neurol"},{"key":"10.1016\/j.lfs.2011.02.020_bb0345","doi-asserted-by":"crossref","first-page":"10483","DOI":"10.1073\/pnas.1832501100","article-title":"Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease","volume":"100","author":"Wang","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.lfs.2011.02.020_bb0350","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.bbrc.2005.12.125","article-title":"The negative cell cycle regulator, Tob (transducer of ErbB-2), is involved in motor skill learning","volume":"340","author":"Wang","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.lfs.2011.02.020_bb0355","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/bj0990667","article-title":"Mechanism of lipid peroxide formation in animal tissue","volume":"99","author":"Wills","year":"1966","journal-title":"Biochem J"},{"key":"10.1016\/j.lfs.2011.02.020_bb0360","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.neuropharm.2005.10.016","article-title":"Diclofenac, a non-steroidal anti-inflammatory drug, suppresses apoptosis induced by endoplasmic reticulum stresses by inhibiting caspase signaling","volume":"50","author":"Yamazaki","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2011.02.020_bb0365","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.neuroscience.2007.09.059","article-title":"Selective inhibition of cyclooxygenase-2 exacerbates methamphetamine-induced dopamine depletion in the striatum in rats","volume":"150","author":"Zhang","year":"2007","journal-title":"Neuroscience"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320511001068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320511001068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T02:04:46Z","timestamp":1740967486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320511001068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":73,"journal-issue":{"issue":"17-18","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0024320511001068"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2011.02.020","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}